⌘K
Loading ticker…
As of 2026-08-24, Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) has a 3-month relative strength percentile of 46 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.4%, relative volume 0.37×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
MDGL is held by 36 ETFs as of May 2026. Top owner: SCHA at 0.20% weight, $44M notional. Top 3 carry $113M.
Held by 86 ETFs · $1.5B across latest filings · largest weight 4.21% (JXX).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.20% | $44M | — |
| VTWO | 0.25% | $44M | −0.01 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.17% | $25M | +0.01 pp |
| VHTVanguard Health Care ETF | 0.12% | $22M | +0.02 pp |
| VTWG | 0.47% | $8M |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| −0.04 pp |
| QQQJ | 0.53% | $6M | +0.05 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $6M | — |
| ILDR | 1.10% | $3M | −0.12 pp |
| ONEQ | 0.02% | $3M | — |
| ESML | 0.10% | $2M | +0.01 pp |
Showing 10 of 36 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MDGL Jan avg: -3.63% median: -3.52% win: 25% σ: 10.26% n: 4 2022-04-12 → 2026-07-31 | MDGL Feb avg: -1.69% median: -2.02% win: 50% σ: 9.06% n: 4 2022-04-12 → 2026-07-31 | MDGL Mar avg: 5.17% median: 5.06% win: 50% σ: 14.53% n: 4 2022-04-12 → 2026-07-31 | MDGL Apr avg: -2.55% median: -1.16% win: 40% σ: 20.40% n: 5 2022-04-12 → 2026-07-31 | MDGL May avg: -4.32% median: -5.16% win: 20% σ: 12.46% n: 5 2022-04-12 → 2026-07-31 | MDGL Jun avg: 5.47% median: 7.98% win: 80% σ: 13.33% n: 5 2022-04-12 → 2026-07-31 | MDGL Jul avg: -6.95% median: -11.13% win: 20% σ: 7.12% n: 5 2022-04-12 → 2026-07-31 | MDGL Aug avg: 8.51% median: 1.24% win: 50% σ: 27.43% n: 4 2022-04-12 → 2026-07-31 (current) | MDGL Sep avg: -9.53% median: -12.01% win: 25% σ: 10.21% n: 4 2022-04-12 → 2026-07-31 | MDGL Oct avg: 3.12% median: 0.15% win: 50% σ: 15.39% n: 4 2022-04-12 → 2026-07-31 | MDGL Nov avg: 30.70% median: 34.53% win: 75% σ: 24.08% n: 4 2022-04-12 → 2026-07-31 | MDGL Dec avg: 79.84% median: 5.68% win: 50% σ: 156.34% n: 4 2022-04-12 → 2026-07-31 |